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Caspase Activation by Granzyme B Is Indirect,
and Caspase Autoprocessing Requires the Release
of Proapoptotic Mitochondrial Factors
ated cell death is dependent on perforin, and perforin-
deficient mice have a susceptibility to pathogenic vi-
ruses (Kagi et al., 1994) and defective surveillance of
neoplastic cells (Smyth et al., 2000; Street et al., 2002;
van den Broek et al., 1996). Interestingly, congenital
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deficiency of granzyme B can be partly compensatedA’Beckett Street
by other granzymes; however, the CL of granzymeMelbourne, 8006
B-deficient mice induce delayed target cell DNA frag-2 Walter and Eliza Hall Institute
mentation (Heusel et al., 1994). Deficiency of either gran-of Medical Research
zyme A or B (but particularly the absence of both gran-Post Office, The Royal Melbourne Hospital
zymes) also results in marked susceptibility to theParkville, 3050
mouse poxvirus ectromelia (Mullbacher et al., 1999b).Australia
This indicates that both granzymes A and B play an
indispensable role in defense against viral pathogens.
In contrast with granule-mediated cell death, engage-Summary
ment of death receptors such as Fas on target cells by
their ligands on CL is important to maintain homeostasisApoptosis in response to granzyme B involves activa-
of lymphoid tissues.tion of caspase-dependent target cell death pathways.
As granzyme B can activate multiple procaspasesHerein, we show that granzyme B initiates caspase
when mixed with them directly (Fernandes-Alnemri etprocessing but cannot fully process procaspase-3 in
al., 1996), it has been presumed that granzyme B wouldintact Jurkat T leukemia or NT2 neuronal cells. Rather,
also activate caspases directly in intact cells. Surpris-the release from mitochondria of proapoptotic media-
ingly, several groups including ours showed that Bcl-2tors cytochrome c, Smac/Diablo, and HtrA2/Omi facili-
overexpressed in mitochondria can block all of the mani-tates full activation of caspases that results from auto-
festations of granzyme B-mediated cell death (Davis etprocessing. Bcl-2 overexpression in mitochondria
al., 2000; Heibein et al., 2000; Sutton et al., 1997), re-suppresses the release of these proapoptotic mole-
sulting in the clonogenic survival of cells (Davis et al.,cules, resulting in cell survival despite partial procas-
2000). Several groups have now shown that granzymepase processing by granzyme B. We propose that
B preferentially activates the mitochondrial pathway tobinding of inhibitor of apoptosis (IAP) proteins to par-
apoptosis by cleaving the proapoptotic BH3-domain-tially processed procaspases inhibits cell death unless
only protein Bid (Barry et al., 2000; Heibein et al., 2000;mitochondrial disruption also occurs in response to
Sutton et al., 2000; Alimonti et al., 2001) specifically atgranzyme B or activated BH3-domain proteins such
Asp75 (Sutton et al., 2000). Thus, co-overexpression ofas truncated Bid.
Bid and Bcl-2 in FDC-P1 cells overcame Bcl-2’s ability
to block granzyme B-induced cell death, even when the
Introduction site cleaved by caspases such as caspase-8 (Asp59)
was mutated (Sutton et al., 2000). In Jurkat cells exposed
Cytotoxic lymphocytes (CL), comprising cytotoxic T even to low nanomolar concentrations of granzyme B
lymphocytes (CTL) and natural killer (NK) cells, kill virus- with perforin, direct cleavage of Bid by granzyme B
infected and neoplastic cells in a contact-dependent commenced within 2 min. By 10 min, Bid was totally
fashion. Exocytosis of the contents of secretory gran- cleaved independently of caspase activity and well be-
ules in the CL cytoplasm results in target cell apoptosis fore any significant activity could be detected (Sutton
through the collaboration of two distinct types of toxin. et al., 2000; Alimonti et al., 2001). While tBid is a very
Perforin, a pore-forming protein, enables granzymes efficient transducer of the granzyme B death signal, it
(granule serine proteases) to access their substrates was recently shown that granzyme B can also activate
(Browne et al., 1999; Metkar et al., 2002), leading to cell death in the absence of Bid. Embryonal fibroblasts
cell death through a combination of caspase-dependent of Bid-deficient mice remained susceptible to granzyme
and -independent pathways (Heibein et al., 1999; Sarin B concentrations in the low micromolar range (Thomas
et al., 1997; Trapani et al., 1998, 2000). The most potent et al., 2001). Thus, granzyme B must be capable of dis-
proapoptotic protease, granzyme B, cleaves its sub- rupting mitochondrial integrity through an alternative
strates after aspartic acid (Odake et al., 1991) and has mechanism/s, albeit with reduced efficiency.
been thought both to activate procaspases directly (Fer- The finding that the granzyme B-induced cell death
nandes-Alnemri et al., 1996; Martin et al., 1996; Yang et is blocked by overexpressing Bcl-2 in mitochondria but
al., 1998) and attack downstream caspase targets to not at other sites such as the ER or plasma membrane
induce cell death (Andrade et al., 1998; Casciola-Rosen (Davis et al., 2000) indicated that mitochondria are indis-
et al., 1999; Sharif-Askari et al., 2001). All granule-medi- pensable for this death pathway. Another surprising
consequence of this finding was that granzyme B could
not, by itself, process cytoplasmic procaspases to com-*Correspondence: j.trapani@pmci.unimelb.edu.au
pletion in intact cells, as occurs when purified granzyme3 Present address: Exelisis, Inc., 170 Harbor Way, P.O. Box 511,
South San Francisco, California 94083. B is mixed with cytoplasmic extracts in vitro (Fernandes-
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Alnemri et al., 1996; Martin et al., 1996). To establish the
molecular and cellular basis for these observations, we
hypothesized that the release of proapoptotic mediators
from mitochondria in response to granzyme B might
be necessary for subsequent caspase processing and
target cell death. The findings outlined below are consis-
tent with this model and indicate that Bid-mediated mi-
tochondrial disruption results in the release of multiple
proapoptotic molecules that are necessary to achieve
complete procaspase processing.
Figure 1. Granzyme B-Cleaved tBid Localizes to Mitochondria
Results and Discussion Jurkat cells preincubated in medium containing either zVAD-fmk or
the control inhibitor zFA-fmk (each 50 M) were exposed to sublytic
perforin (P) alone or P with granzyme B (GrB, 50 nM) or in theEffective synergy between the two principal granule-
absence of both toxins (C) for 60 min, then fractionated to separatebound CL toxins, perforin, and granzymes is essential
the soluble cytosolic proteins from the membrane fraction, whichfor mounting an effective immune response against vari-
contained the mitochondria (see Experimental Procedures). West-
ous intracellular pathogens (Heusel et al., 1994; Kagi ern blot analysis was then performed with an antiserum detecting
et al., 1994; Mullbacher et al., 1999a, 1999b) and for human Bid. The same fractions were also probed with antisera de-
protection against carcinogen-induced (Smyth et al., tecting cytochrome c oxidase (CCO, an integral mitochondrial pro-
tein) and procaspase-3 (which is not normally found in mitochondria)2000; van den Broek et al., 1996) and spontaneous ma-
to determine the extent of crosscontamination of the cytoslic andlignancy (Smyth et al., 2000; Street et al., 2002). Caspase
membrane fractions.activation is potently induced in cells exposed to gran-
zyme B and perforin. However, the recent finding of
several groups that Bcl-2 overexpression potently
depleted from the cytosol (Figure 1). We previouslyblocks granzyme B-mediated apoptosis and bestows
showed that tBid-induced mitochondrial disruption inclonogenic survival to cells suggested that caspase acti-
response to granzyme B occurs independently of cas-vation is crucially dependent on the mitochondrial path-
pases, as Bid is cleaved directly by granzyme B priorway rather than direct procaspase processing by gran-
to and without a need for caspase activation (Sutton etzyme B.
al., 2000). In the current study, both Bid cleavage and
mitochondrial localization of tBid were unaffected by
preincubating the cells with the poly-caspase inhibitorBid Truncated by Granzyme B Localizes
Val-Ala-Asp-fluoromethylketone (zVAD-fmk) or the ca-to Mitochondria
thepsin B inhibitor Phe-Ala- (FA) fmk, which was usedOur previous studies showed that the BH3-domain-only
as a control. As expected, tBid was not detected, norprotein Bid is rapidly cleaved by granzyme B in Jurkat
was intact Bid depleted in response to perforin alonehuman leukemia cells or mouse FDC-P1 promyelocytic
or in the absence of perforin and granzyme B (Figureleukemia cells on the carboxyl side of Asp75, a cleavage
1). Crosscontamination of the membrane and cytosolicsite conserved in human and rodent Bid. Bid cleavage
fractions was minimal, as unprocessed 32 kDa procas-occurs irrespective of whether Bcl-2 is overexpressed
pase-3, exclusively a cytosolic protein (van Loo et al.,(Sutton et al., 2000), placing Bid cleavage upstream of
2002), was not detectable in the membrane fractions,mitochondrial disruption in the granzyme B death cas-
whereas cytochrome c oxidase, which is located at thecade. Truncated Bid has been shown to translocate and
inner mitochondrial membrane, was not found in theintegrate into the mitochondrial outer membrane (Li et
cytosolic fractions (Figure 1). Thus, Bid cleaved by gran-al., 1998; Luo et al., 1998). Recent evidence suggests
zyme B localizes to mitochondria, just as it does whenthat tBid acts as a death ligand by binding to either
cleaved by caspases (Gross et al., 1999; Luo et al., 1998).Bax in the cytosol (Eskes et al., 2000) and/or BAK in
mitochondria, resulting in a conformational change in
these molecules, their homo-oligomerization, and inser- Release of Multiple Mitochondrial Proapoptotic
tion into the outer mitochondrial membrane. This is Molecules in Response to Granzyme B
thought to create a pore in the outer membrane which Mitochondria can release several proapoptotic media-
allows the release of cytochrome c and possibly other tors to initiate caspase activation in the cytoplasm, clas-
proapoptotic mediators (Wei et al., 2000, 2001). Alterna- sically in response to Bcl-2-inhibitable death stimuli
tively, structural data has predicted that tBid may itself such as growth factor withdrawal,  irradiation, or cyto-
homo-oligomerize and form pore-like structures in the toxic drugs including staurosporine. These factors in-
outer membrane (Grinberg et al., 2002; Schendel et al., clude cytochrome c (Liu et al., 1996), Smac/Diablo (Du
1999). et al., 2000; Verhagen et al., 2000), HtrA2/Omi (Hegde
To determine whether granzyme B-cleaved tBid trans- et al., 2002; Martins et al., 2002; Verhagen et al., 2002),
locates to mitochondria, we exposed Jurkat cells to endonuclease G (Li et al., 2001; Parrish et al., 2001),
perforin and granzyme B, then lysed and fractionated and apoptosis-inducing factor (AIF) (Susin et al., 1999).
the cells into a membrane fraction containing mitochon- Cytochrome c is a cofactor for apoptosome formation
dria and soluble cytosolic extract. Western blot analysis with procaspase-9 and Apaf-1, resulting in caspase-9
indicated that tBid became localized almost entirely in activation (Liu et al., 1996). Both Smac/Diablo and Htr2A/
Omi exert their action by displacing inhibitor of apopto-the membrane fraction, while uncleaved Bid was largely
Caspase Activation by Granzyme B
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Figure 2. Release of Cytochrome c, Smac, and HtrA2 from Mitochondria in Response to Granzyme B
(A) Jurkat cells preincubated in medium containing either zVAD-fmk or the control inhibitor zFA-fmk were exposed to sublytic perforin (P)
alone or P with granzyme B (GrB, 50 nM) for the minutes indicated, or to anti-human Fas IgM (clone CH11, 250 ng/ml) or control IgM (C) for
the hours indicated and then fractionated using a digitonin lysis buffer to separate the soluble cytosolic proteins from the membrane fraction,
which contained the mitochondria (see Experimental Procedures). Western blot analysis was then performed with antisera detecting human
cytochrome c, Smac, HtrA2, and cytochrome c oxidase (CCO).
(B) Jurkat cells were preincubated in medium containing zVAD-fmk or the control inhibitor zFA-fmk (50 M), then exposed to sublytic perforin,
P with granzyme B (50 nM) for 60 min, anti-human Fas IgM (clone CH11, 250 ng/ml), or control IgM for 4 hr. The DNA was then extracted,
separated by pulsed-field gel electrophoresis, and probed for the presence of repetitive DNA sequences.
(C) Western blots showing the release of cytochrome c into the supernatant (sn) or remaining in the membrane fraction (memb) after mouse
liver mitochondria were exposed to purified recombinant FL-Bid, D60tBid, or D75tBid for the number of minutes indicated (see Experimental
Procedures).
Immunity
322
sis (IAP) proteins, such as XIAP/Miha bound to procas- Omi were all released in response to granzyme B and
pases-3 and -9, to promote caspase autoactivation perforin, cells treated in a similar fashion did not display
(Chai et al., 2000; Srinivasula et al., 2000, 2001; Wu et al., AIF activity. Using pulsed-field gel electrophoresis, we
2000). IAPs contain an amino-terminal repeat domain, observed large (approximately 4–50 kb) DNA fragments
termed the baculovirus-IAP repeat (BIR), and a carboxy- in response to both perforin/granzyme B and anti-Fas
terminal RING zinc finger domain (Clem and Miller, IgM. In each case, however, DNA fragmentation was
1994). Six human IAP-like molecules have been identi- abolished by inhibiting caspases with zVAD-fmk (Figure
fied, of which XIAP is the most potent inhibitor of cas- 2B) and therefore could not have been induced by AIF
pases-3, -7, and -9 (Deveraux and Reed, 1999). The IAPs (Susin et al., 1999).
act by directly binding to different caspases through Granzyme B and caspases cleave Bid at different sites
distinct domains; the BIR2 domain is responsible for (Li et al., 1998), so that the C-terminal tBid molecules
inhibiting caspases-3 and -7, whereas the BIR3 domain produced by granzyme B are 15 (mouse) or 16 (human)
binds and inhibits caspase-9 (Chai et al., 2001; Deveraux residues shorter than those produced by caspases such
et al., 1999; Ekert et al., 2001; Huang et al., 2001; Riedl as caspase-8. To determine whether the two types of
et al., 2001; Takahashi et al., 1998). Both structural and tBid differ significantly in their ability to disrupt mito-
functional studies have shown that Smac/Diablo and chondria, we exposed isolated rat liver mitochondria to
HtrA2/Omi can promote caspase activation and over- either form of tBid or to full-length human Bid (FL-Bid),
come inhibition by IAPs by directly interacting with them. all of which were expressed in bacteria. tBid molecules
The amino-terminus of Smac and processed HtrA2 is corresponding to residues 61–195 (D60tBid) or 76–195
crucial to this interaction, in particular, the first 4 amino (D75tBid) of FL-Bid induced kinetically equivalent re-
acids (AVPI/S/A) (Liu et al., 2000; Riedl et al., 2001; Srini- lease of cytochrome c (minor quantitative differences in
vasula et al., 2000, 2001). There is also sequence homol- the experiment shown were not reproducible). By con-
ogy of this region to the Drosophila proteins Reaper, trast, FL-Bid produced little or no cytochrome c release
Hid, and Grim, which also act by neutralizing IAP func- (Figure 2C). The release of Smac/Diablo or HtrA2/Omi
tion (Chai et al., 2000; Du et al., 2000; Verhagen et al., in response to D60tBid or D75tBid was also equivalent
2000). In contrast with caspase-dependent cell death, (data not shown). Therefore, we found no evidence for
AIF is thought to induce caspase-independent nuclear functional differences between the tBid molecules pro-
damage by promoting fragmentation of DNA (Susin et duced by granzyme B- and caspase-mediated pro-
al., 1999). cessing.
To determine which, if any, of these mediators can
be released from mitochondria in response to granzyme Release of Cytochrome c, Smac/Diablo,
B-cleaved tBid, Jurkat cells exposed to perforin and and HtrA2/Omi Is Inhibitable by Bcl-2
granzyme B were fractionated using a digitonin lysis We next examined the effects of Bcl-2 overexpression
buffer and then analyzed for the intracellular distribution on the release of cytochrome c, Smac/Diablo, and
of cytochrome c, Smac/Diablo, and HtrA2/Omi (Figure HtrA2/Omi from isolated mitochondria and in intact
2A). Cytochrome c was detectable in the cytosolic frac-
cells. Consistent with our findings that cells overex-
tion within 2 min, and its signal became progressively
pressing Bcl-2 are resistant to granzyme B-induced cell
attenuated in the corresponding mitochondria-con-
death (Davis et al., 2000; Sutton et al., 1997), we found
taining membrane fractions. By contrast, cytochrome c
that Bcl-2 overexpression in Jurkat cells (Jukat.bcl2)remained exclusively in the membrane fraction in cells
completely inhibited the release of all three proapoptoticexposed to perforin alone (or granzyme B alone; data
factors from mitochondria. However, Jurkat cells trans-not shown) for up to 90 min. Very similar results were
fected with vector DNA alone (Jurkat.pgk) released allobtained when the same fractions were assayed for
three molecules (Figure 3A) and underwent apoptosisSmac/Diablo or HtrA2/Omi, indicating that all three pro-
(Sutton et al., 1997 and data not shown) in responseapoptotic mediators are released from mitochondria
to granzyme B/perforin. Similarly, the release of Smac/within 2–30 min of exposure to granzyme B and perforin
Diablo (Figure 3B), cytochrome c, and HtrA2/Omi (data(Figure 2A). The release of none of the mitochondrial
not shown) from mitochondria isolated from Jurkat.bcl2molecules was inhibited by preincubating the cells with
cells was completely inhibited in response to both puri-zVAD-fmk (50 M). However, the release of all three
fied D60tBid (caspase-cleaved) and D75tBid (granzymemolecules was completely inhibited by zVAD-fmk in re-
B-cleaved). Whereas inactivation of caspases had nosponse to anti-Fas IgM (Figure 2A, lower panel). This was
effect on the release of cytochrome c, Smac/Diablo, orbecause Bid cleavage and subsequent mitochondrial
HtrA2/Omi, our results indicated that Bcl-2 was able todisruption in response to Fas ligation are dependent on
regulate the essential initial steps involved in mitochon-prior caspase activation. The kinetics of release of all
drial disruption in response to granzyme B-cleaved tBid.three proapoptotic mediators was similar to another
By abolishing subsequent caspase activation in re-study (Madesh et al., 2002), suggesting all three media-
sponse to granzyme B, Bcl-2 overexpression also totallytors may utilize a common mechanism of efflux from
inhibited DNA fragmentation (Figure 3C). By contrast,mitochondria. Both sets of findings contrast somewhat
Bcl-2 overexpression did not affect DNA fragmentationwith another study (Adrain et al., 2001), which found that
(or cell death; see Sutton et al., 2000) when the samecytochrome c was released independently of caspase
cells were killed through the Fas pathway, indicatingactivation in response to stress-related stimuli (cyto-
that caspase activation in response to Fas-crosslinkingtoxic drugs and UV), whereas Smac/Diablo release was
did not require participation of mitochondria (Figure 3C)significantly reduced by pretreating cells with zVAD-
fmk. Although cytochrome c, Smac/Diablo, and HtrA2/ (Huang et al., 1999).
Caspase Activation by Granzyme B
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Figure 3. Inhibited Release of Cytochrome c, Smac, and HtrA2 by Bcl-2 Overexpression in Mitochondria in Response to Granzyme B
(A) Jurkat.bcl2 or Jurkat.pgk cells were exposed to sublytic perforin (P) alone or to P with granzyme B (GrB, 50 nM) for the minutes
indicated and then fractionated to separate the soluble cytosolic proteins from the membrane fraction, which contained the mitochondria
(see Experimental Procedures). Western blot analysis was then performed with antisera detecting human cytochrome c, Smac, and HtrA2.
(B) Western blot showing the release of Smac into the supernatant (sn) or remaining in the membrane fraction (memb) when mitochondria
purified from Jurkat.pgk or Jurkat.bcl2 cells were exposed to purified recombinant FL-Bid, D60tBid, or D75tBid for the number of minutes
indicated (see Experimental Procedures).
(C) Pulsed-field gel electrophoresis of DNA isolated from Jurkat.pgk or Jurkat.bcl2 cells exposed to sublytic perforin alone or P with granzyme
B (50nM) for 60 min, or to anti-human Fas IgM (clone CH11, 250 ng/ml) or control IgM (C) for 4 hr.
Direct Procaspase Processing by Granzyme B dria and prevents the release of cytochrome c, Smac/
Diablo, and HtrA2/Omi. These results were surprising, asIs Minimal in Intact Jurkat Cells
The findings outlined above clearly indicated that cell it has been assumed that granzyme B directly processes
and activates caspases. During their autoprocessing,death in response to granzyme B is associated with the
release of multiple proapoptotic mediators from mito- caspases such as caspase-3 are cleaved at a number
of sites, permitting their refolding and incremental acqui-chondria, whereas overexpression of Bcl-2, which inhib-
its granzyme B-induced cell death, stabilizes mitochon- sition of activity. For procaspase-3, initial processing
Immunity
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Figure 4. Partial Processing of Procaspase-3 in Intact Jurkat Cells
Exposed to Perforin and Granzyme B
Western blot analysis of cytosolic extracts of Jurkat cells preincu-
bated in medium containing either zVAD-fmk or the control inhibitor
zFA-fmk (each 50 M) and then exposed to sublytic perforin (P)
alone or P with granzyme B (GrB, 50 nM) for the times indicated.
takes place at Asp175, resulting in formation of a p20
heavy chain, which associates with the p10 light chain.
The heavy chain is then autoprocessed further, near its
amino-terminus at Asp9 and 28 to produce the more
potent p19 and p17 forms (Fernandes-Alnemri et al.,
1996). However, unlike what is observed when granzyme
B is added to cytosolic extracts or purified procaspases,
we found that extensive processing of procaspases by
granzyme B did not take place in intact cells. A small
proportion of the total cellular procaspase-3 was
cleaved to produce the p20 species within 10 min of
Jurkat cells being exposed to purified perforin/gran-
zyme B (Figure 4). Further processing, with production
of p19 was seen by 40 min. Preincubation of the cells
with zVAD-fmk (but not FA-fmk) had no quantitative or
kinetic effect on the appearance of the p20 fragment,
but further processing was completely abolished. These
results confirmed that granzyme B is able to initiate the
processing of procaspase-3 directly, but further pro-
cessing to fully active caspase-3 requires caspase auto-
catalysis.
When Jurkat cells overexpressing Bcl-2 were exposed
to granzyme B/perforin (Figure 5), similar early partial
processing of procaspase-3 to the p20 form was ob- Figure 5. Early Partial Processing of Procaspase-3 but Not Procas-
pase-9 in Jurkat.blc2 Cells in Response to Granzyme Bserved; however, further processing was abolished, and
(A) Western blot analysis, using mouse anti-caspase 3 (Transductionthe cells survived (Sutton et al., 2000 and data not
Laboratories) or mouse anti-caspase 9 antisera of cytosolic extractsshown). By contrast, Bcl-2 overexpression did not affect
of Jurkat.pgk or Jurkat.bcl2 cells exposed to sublytic perforin (P)procaspase-3 processing in response to Fas crosslink-
alone or P with granzyme B (GrB, 50 nM) for the minutes indicated,
ing, and cell death resulted (data not shown). Early pro- to anti-human Fas IgM for the hours indicated (clone CH11, 250 ng/
cessing of procaspase-9 was not observed in response ml), or to control IgM (C) for 5 hr.
to granzyme B when Bcl-2 was overexpressed, indicat- (B) Caspase-3 and -9 activities in cytosolic extracts of Jurkat cells
(50 g) exposed to perforin with or without granzyme B (50 nM).ing that procaspase-9 is a poor substrate or is inaccessi-
Enzymic activities were estimated as a function of time, using able to granzyme B in intact cells (Figure 5A). We also
colorimetric assay to determine the turnover of the peptide sub-measured caspase activity in the same cells by examin-
strates DEVD-pNA (caspase-3) and LEHD-pNA (caspase-9). The ex-
ing the turnover of oligopeptide caspase substrates (Fig- periment shown is representative of three similar experiments.
ure 5B). Consistent with our Western blot findings, mini-
mal caspase-3 activity was detected in Jurkat.pgk cells
at 15 min, when only the p20 form had been generated. tion of the p20 chain in Bcl-2-overexpressing Jurkat
cells did not produce sufficient caspase-3 activity toBy 30 or 45 min, specific caspase-3 activity had in-
creased by about 20-fold, but this increase was com- result in cell death. The results for caspase-9 activity
followed a very similar pattern, although substrate turn-pletely inhibited in Jurkat.bcl2 cells. Therefore, genera-
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insufficient to kill Jurkat or NT2 cells. Our findings that
further caspase processing is inhibited by zVAD-fmk
also clearly indicate that the completion of caspase pro-
cessing in cells dying in response to granzyme B is
mediated by caspases themselves. Further caspase
processing also stalls if Bcl-2 is overexpressed, as the
release from mitochondria of three potent inducers of
apoptosis, cytochrome c, Smac/Diablo, and HtrA2/Omi,
is blocked.
In the absence of Bcl-2 overexpression, our data indi-
cate a chain of events that progressively leads to cas-
pase activation and cell death. These events can be
divided into three phases: early, intermediate, and late
(Figure 7). Immediately upon reaching the cytosol (first
10 min, early phase) granzyme B performs two distinct
functions. Its optimal substrate is Bid, and Bid cleavage
after Asp75 is followed by tBid insertion into the mito-
chondrial outer membrane. In addition, granzyme B
cleaves a small amount of procaspase-3 at Asp175,
thereby sensitizing the caspase cascade for subse-
quent, more potent activation. We found no evidence
that procaspase-9 is directly processed by granzymeFigure 6. Procaspase-3 Processing in Human NT2 Cells in Re-
B; however, our previous studies indicated that procas-sponse to Granzyme B Is Dictated by the Relative Levels of Miha
and Smac Expression pase-8 may also undergo early partial processing by
granzyme B (Sutton et al., 2000). Further autoprocessing(A) Western blot analysis, using antiserum to human caspase-3, of
parental NT2 cells transfected with vector DNA alone (NT2) or stably of procaspases in this early phase is inhibited by binding
expressing the mouse IAP Miha (NT2.Miha), exposed for varying of IAPs such as XIAP/Miha, through the interaction of
numbers of hours to perforin (P) with or without granzyme B (GrB). the BIR2 domain with caspase 3 (Deveraux and Reed,
(B) Western blot analysis, using antiserum to human caspase-3, of
1999). In the event that a cell expresses large amountsNT2.Miha cells or NT2.Miha cells transiently transfected to express
of Bcl-2, this would insure that caspase activity doesSmac/Diablo lacking a mitochondrial localization motif (see Experi-
not reach a critical threshold that results in cell death.mental Procedures), exposed for varying numbers of hours to per-
forin with or without granzyme B or to neither toxin (C). In the early phase, destabilization of the mitochondrial
membrane occurs in response to tBid, and the release
of proapoptotic mediators commences. Our kinetic
studies indicate cytochrome c release occurs within justover was generally much lower than for caspase-3 (Fig-
2 min, and Smac/Diablo and HtrA2/Omi are released ature 5B).
approximately 10–20 min. Of course, this time frame is
only approximate, as our estimates are influenced byOverexpression of XIAP/Miha Stalls Caspase-3
the different sensitivity of the various antisera used inProcessing in NT2 Cells
our Western blots. The intermediate phase (10–30 min)To test whether IAPs are able to regulate caspase activa-
is the stage of commitment to cell death. By this phase,tion in response to granzyme B, we examined caspase-
the release of cytochrome c, Smac/Diablo, and HtrA2/3 processing in human NT2 neuronal cells stably overex-
Omi is accelerating, and the IAP brake is removed frompressing XIAP/Miha (NT2.Miha, Figure 6A). Consistent
caspase autoprocessing. Our data suggest that thewith our findings in Jurkat cells, parental NT2 cells gen-
most crucial step is that Smac/Diablo and HtrA2/Omierated both the p20 and p17 caspase-3 fragments,
displace XIAP and similar inhibitors from procaspase-3,whereas only the p20 fragment was generated in
permitting its autocatalysis. Although cytochrome c isMT2.Miha cells. These data indicated that caspase-3
released very early, we saw no evidence that caspase-9activity in cells exposed to granzyme B/perforin is dic-
processing occurs prior to caspase-3 activation. How-
tated by the balance of proapoptotic (Smac/Diablo,
ever, we cannot totally exclude the possibility that cas-
HtrA2/Omi) and antiapoptotic molecules (XIAP/Miha)
pase-9 may be partly active in this phase, as it has been
they express. Consistent with this proposition, we also shown that this caspase can have constitutive activity
found that NT2.Miha cells transiently transfected to ex- in its unprocessed state (Srinivasula et al., 2001; Sten-
press a cytoplasmic form of Smac that lacks a mitochon- nicke et al., 1999). Ultimately, we believe it is likely that
drial localization motif became able to process some all three proapoptotic mediators released from mito-
procaspase-3 to the p17 form (Figure 6B). chondria contribute significantly to cell death and that
the question of which mediator is most important in any
A Model of Caspase-Mediated Cell Death one cell type can only be resolved using cells derived
Induced by Granzyme B from gene-disrupted mice as target cells. In the late
Our current findings clearly show that granzyme B phase, the phenotypic changes typical of caspase-
largely achieves caspase activation indirectly, rather mediated cell death take place. Activated caspase-3 is
than by directly processing procaspases. Thus, the mi- able to cleave other procaspases and key downstream
nor direct procaspase-3 processing that takes place substrates such as the inhibitor of caspase-activated
DNase (iCAD) (Sakahira et al., 1998), leading to DNAwithin minutes of granzyme B reaching the cytosol is
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Figure 7. A Model of Caspase Activation by
Granzyme B in Cells Expressing Low/Normal
or High Levels of Bcl-2
Upon entry into the cytosol from the endoso-
mal compartment (early phase), granzyme B
efficiently cleaves Bid at D75 and com-
mences the partial processing of procas-
pase-3 at D175. XIAP binds to partially pro-
cessed procaspase-3 (p20). All of these
events take place when Bcl-2 is overex-
pressed in mitochondria; however, D75tBid
is unable to induce the release of cytochrome
c, Smac/Diablo, and HtrA2/Omi when Bcl-2
is overexpressed. In cells overexpressing
Bcl-2, XIAP therefore remains bound to p20,
a sufficient threshold of caspases activation
is not reached, and the cells survive. By con-
trast, when low/normal levels of Bcl-2 are ex-
pressed, Smac/Diablo and HtrA2/Omi can
displace XIAP from p20, permitting further
caspase processing at D28 and D9 (interme-
diate phase). In the absence of Bcl-2 overex-
pression (Jurkat.pgk cells), full caspase pro-
cessing (to p19 and p17) and activation occur
in the late phase, leading to typical apoptosis
which is manifested by changes including
DNA fragmentation following cleavage of
iCAD by caspase-3 and other activated cas-
pases (see text for fuller details).
Experimental Proceduresfragmentation and the many other changes typical of
apoptosis.
Cell LinesWe have shown that Bcl-2 overexpression potently
Jurkat human leukemia and NT2 neuronal cells were cultured in
inhibits granzyme B-induced apoptosis in multiple he- RPMI medium supplemented with 10% bovine fetal serum in a hu-
matopoietic cells of humans and mice, including Jurkat midified incubator containing 5% CO2 in air. The production, charac-
terization, and maintenance of Jurkat cells transfected to overex-(human lymphoid) (Sutton et al., 2000), FDC-P1 (mouse
press human Bcl-2 (Jurkat.bcl2) is described elsewhere (Davis etmyeloid) (Davis et al., 2000; Sutton et al., 1997, 2000),
al., 2000). Control Jurkat cells were also produced in which vectorand Yac-1 (mouse lymphoid) (Sutton et al., 1997). This
DNA only was introduced (Jurkat.pgk). Human NT2 neuronal cells
suggests that Bcl-2 is a crucial regulator of granzyme overexpressing Miha (NT2.Miha; Ekert et al., 2001) were obtained
B-induced cell death in hematopoietic cells. It remains from Dr. P. Ekert (Walter and Eliza Hall Institute, Melbourne) and
to be tested whether this is also the case in other cell maintained in DMEM containing puromycin (8 g/ml). For transient
transfection, NT2.Miha cells (5  10e5) plated in 75 cm2 culturetypes. It is important to point out that while Bid is clearly
dishes were mixed with pEFdeltaN.Diablo plasmid DNA (4 g) en-an excellent substrate for granzyme B, cell death still
coding Diablo which lacks a mitochondrial targeting sequence (ob-occurred when embryonal fibroblasts of Bid-deficient
tained from Dr. P. Ekert), and a reporter plasmid encoding the green
mice were exposed to granzyme B and perforin (Thomas fluorescent protein (1 g). DNA was introduced into the cells using
et al., 2001). This may be for any of several reasons. lipofectamine. Forty-eight hours later, the cells were harvested, ana-
lyzed for GFP expression on a cytofluorograph, and then exposedFirst, caspase processing may be regulated differently in
to perforin and granzyme B as described below.fibroblasts and may not be dependent on mitochondrial
perturbation. Alternatively, as Bid is only one of several
proapoptotic BH3 domain-only proteins, other family Apoptosis Assays
members may be able to compensate for the absence Perforin was purified from rat NK cells as described (Sutton et al.,
1997). A sublytic dose of perforin induced 10% specific releaseof Bid.
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of 51Cr over 4 hr. Purification of human granzyme B from YT cells human HtrA2 (generously provided by Dr. Srinivasa Srinivasula, Kim-
mel Cancer Institute, Philadelphia, PA). Bound Ig was detected withwas as described (Trapani et al., 1993). zVAD-fmk and zFA-fmk were
purchased from Enzyme Systems Products. Jurkat, Jurkat.pgk, or rabbit anti-mouse or swine anti-rabbit reagent coupled to horserad-
ish peroxidase after chemiluminescent amplification.Jurkat.bcl2 cells were exposed to perforin and granzyme B as de-
scribed (Sutton et al., 2000). In some experiments, the cells were
treated with mouse anti-Fas IgM antibody (250 ng/ml CH11, Upstate Pulsed-Field Gel Electrophoresis
High molecular weight DNA was prepared from 2 million JurkatBiotechnology). Caspase activities were estimated by measuring
turnover in colorimetric assays of the substrates DEVD-pNA (cas- cells treated with various apoptotic stimuli, resolved through a 1%
agarose/TBE gel by pulsed-field electrophoresis (Biorad CHEF-pase-3) and LEHD-pNA (caspase-9) (Biomol Research Laboratories,
Plymouth, PA). Mapper, 1-30 s pulse, 6 V/cm, 14C), transferred to a nylon mem-
brane, and probed with 32P-dATP-labeled human COT-1 DNA (100
ng, Gibco-BRL).Cell Fractionation
To determine the subcellular location of tBid, 10 million Jurkat cells
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